Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

A porous hydrogel-electrospun composite scaffold made of oxidized alginate/gelatin/silk fibroin for tissue engineering application.

Hajiabbas M., Alemzadeh I., Vossoughi M.

Animal Study, published in Carbohydr Polym (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Carbohydr Polym (2020)
Country
England
Reported sample size
—
Source database
PubMed
PMID
32718603
DOI
10.1016/j.carbpol.2020.116465

Abstract (original English)

In the article, a bilayer nanocomposite scaffold made of oxidized alginate (OAL), gelatin (G), and silk fibroin (SF) has been prepared via combining electrospinning, in situ gas foaming, in situ crosslinking and freeze drying methods. The physicochemical and mechanical properties, as well as thermal stability of the proposed composite, have been investigated by SEM, FTIR, XRD, tensile, and TGA analysis. The data indicate that structure and degree of crosslinking play a vital role in adjusting the physical and mechanical properties of composite scaffolds. Further, the authors find a favorable adipose-derived mesenchymal stem cell's (AMSC) attachment and distribution within this novel hydrogel-electrospun composite. Such a nanocomposite structure with its promising properties and cell-material interaction may be considered as a new scaffold for different tissue engineering applications.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AlginatesAnimalsCell ProliferationCell SurvivalCross-Linking ReagentsFibroinsGelatinHydrogelsMesenchymal Stem CellsNanocomposites

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.